147 related articles for article (PubMed ID: 30820705)
1. Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients.
Łukaszewicz-Zając M; Pączek S; Muszyński P; Kozłowski M; Mroczko B
Clin Exp Med; 2019 May; 19(2):191-199. PubMed ID: 30820705
[TBL] [Abstract][Full Text] [Related]
2. CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression.
Pączek S; Łukaszewicz-Zając M; Gryko M; Mroczko P; Kulczyńska-Przybik A; Mroczko B
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192002
[No Abstract] [Full Text] [Related]
3. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of receptor for interleukin 8 in patients with esophageal cancer.
Łukaszewicz-Zając M; Kulczyńska-Przybik A; Muszyński P; Kozłowski M; Szmitkowski M; Mroczko B
Pol Arch Med Wewn; 2016 Oct; 126(11):854-861. PubMed ID: 27906878
[TBL] [Abstract][Full Text] [Related]
5. The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Szmitkowski M
Dis Markers; 2016; 2016():7963895. PubMed ID: 27041792
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of CXCL-8/CXCR-2 network in esophageal squamous cell carcinoma.
Ogura M; Takeuchi H; Kawakubo H; Nishi T; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Miyasho T; Yamada S; Kitagawa Y
Surgery; 2013 Sep; 154(3):512-20. PubMed ID: 23972657
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Serum Chemokines in Esophageal Cancer.
Li Z; Qian J; Li J; Zhu C
Med Sci Monit; 2019 Aug; 25():5850-5855. PubMed ID: 31385574
[TBL] [Abstract][Full Text] [Related]
8. Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus.
Gockel I; Dirksen K; Messow CM; Junginger T
World J Gastroenterol; 2006 Jun; 12(23):3746-50. PubMed ID: 16773693
[TBL] [Abstract][Full Text] [Related]
9. The alcohol dehydrogenase isoenzyme (ADH IV) as a candidate tumour marker of esophageal cancer.
Jelski W; Laniewska-Dunaj M; Niklinski J; Kozłowski M; Laudanski J; Szmitkowski M
Acta Biochim Pol; 2013; 60(3):489-93. PubMed ID: 24051444
[TBL] [Abstract][Full Text] [Related]
10. Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEA.
Litman-Zawadzka A; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B
Pol Arch Intern Med; 2018 Sep; 128(9):524-531. PubMed ID: 30057378
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay.
Horala A; Swiatly A; Matysiak J; Banach P; Nowak-Markwitz E; Kokot ZJ
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075407
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum HGF and CK18 levels in patients with esophageal cancer.
Kilic-Baygutalp N; Ozturk N; Orsal-Ibisoglu E; Gündogdu B; Ozgeris FB; Bakan N; Bakan E; Kilic AF
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706656
[TBL] [Abstract][Full Text] [Related]
13. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
[TBL] [Abstract][Full Text] [Related]
14. The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma.
Li Z; Xu H; Yu J; Liu C; Zheng C; Zeng R; Xu L; Li E; Peng Y; Xu Y
Cancer Control; 2021; 28():10732748211004883. PubMed ID: 33926265
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
Knychalski B; Lukieńczuk T
Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels and diagnostic utility of macrophage-colony stimulating factor, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 as tumor markers in cervical cancer patients.
Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Gacuta E; Szmitkowski M; Chrostek L; Ławicki S
Tumour Biol; 2018 Jul; 40(7):1010428318790363. PubMed ID: 30052166
[TBL] [Abstract][Full Text] [Related]
18. Serum interleukin-12 and interleukin-18 levels in patients with oesophageal squamous cell carcinoma.
Diakowska D; Markocka-Maczka K; Grabowski K; Lewandowski A
Exp Oncol; 2006 Dec; 28(4):319-22. PubMed ID: 17285118
[TBL] [Abstract][Full Text] [Related]
19. Exploring Potential Biomarkers in Oesophageal Cancer: A Comprehensive Analysis.
Romanowicz A; Lukaszewicz-Zajac M; Mroczko B
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673838
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
